NOVONIX Ltd

As of June 30, 2026, NOVONIX Ltd carries a market capitalization of 148.74M, placing it among publicly traded companies globally. Its enterprise value stands at 194.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

NOVONIX Ltd's next confirmed earnings release is scheduled for March 4, 2027.

As of June 30, 2026, NOVONIX Ltd has 991.60M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, NOVONIX Ltd maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, NOVONIX Ltd's stock has declined approximately 90.00% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.22.

As of June 30, 2026, NOVONIX Ltd holds 86.03M in cash and equivalents against 131.95M in total debt, resulting in a net debt position of 35.83M. Total book value stands at 227.35M, with working capital of -3.66M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, NOVONIX Ltd paid dividends of - - per share. Total shareholder yield is negative at -54.75, meaning NOVONIX Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

NOVONIX Ltd's most recent stock split took place on May 29, 2020 with a 95:132 split ratio.